ES2141065T1 - Preparacion de vacunas subunitarias contra el virus sincitial respiratorio. - Google Patents
Preparacion de vacunas subunitarias contra el virus sincitial respiratorio.Info
- Publication number
- ES2141065T1 ES2141065T1 ES97930274T ES97930274T ES2141065T1 ES 2141065 T1 ES2141065 T1 ES 2141065T1 ES 97930274 T ES97930274 T ES 97930274T ES 97930274 T ES97930274 T ES 97930274T ES 2141065 T1 ES2141065 T1 ES 2141065T1
- Authority
- ES
- Spain
- Prior art keywords
- virus
- sincitial
- respiratory
- proteins
- subunitary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title abstract 5
- 230000000241 respiratory effect Effects 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- 239000011159 matrix material Substances 0.000 abstract 2
- 238000010171 animal model Methods 0.000 abstract 1
- 239000003599 detergent Substances 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000004927 fusion Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000005342 ion exchange Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18521—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18551—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
Abstract
PROTEINAS DE FUSION (F), DE ENLACE (G) Y DE MATRIZ (M) DEL VIRUS SINCITIAL RESPIRATORIO (RSV) QUE SE AISLAN Y PURIFICAN A PARTIR DEL VIRUS SINCITIAL RESPIRATORIO POR EXTRACCION AL DETERGENTE SUAVE DE LAS PROTEINAS DEL VIRUS CONCENTRADO. ESTE PROCEDIMIENTO CONSISTE EN CARGAR LA PROTEINA EN UNA COLUMNA DE HIDROXIAPATITA U OTRA COLUMNA DE MATRIZ INTERCAMBIADORA DE IONES Y EN ELUIR LA PROTEINA CON UN TRATAMIENTO SUAVE CON SAL. DICHAS PROTEINAS F, G Y M, FORMULADAS EN FORMA DE COMPOSICIONES INMUNOGENAS, SON SEGURAS Y ALTAMENTE INMUNOGENAS Y PROTEGEN MODELOS ANIMALES PERTINENTES CONTRA LA ENFERMEDAD DEBIDA A LA INFECCION PROVOCADA POR EL VIRUS SINCITIAL RESPIRATORIO.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/679,060 US6020182A (en) | 1996-07-12 | 1996-07-12 | Subunit respiratory syncytial virus vaccine preparation |
US679060 | 1996-07-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
ES2141065T1 true ES2141065T1 (es) | 2000-03-16 |
ES2141065T3 ES2141065T3 (es) | 2005-05-01 |
ES2141065T5 ES2141065T5 (es) | 2009-02-16 |
Family
ID=24725423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES97930274T Expired - Lifetime ES2141065T5 (es) | 1996-07-12 | 1997-07-11 | Preparacion de una vacuna de sub-unidades contra el virus respiratorio sincitial. |
Country Status (15)
Country | Link |
---|---|
US (2) | US6020182A (es) |
EP (2) | EP0942928B2 (es) |
JP (1) | JP2000501418A (es) |
CN (1) | CN1145639C (es) |
AT (1) | ATE282633T1 (es) |
AU (1) | AU716378B2 (es) |
BR (1) | BR9712970A (es) |
CA (1) | CA2259594C (es) |
DE (2) | DE69731659T3 (es) |
ES (1) | ES2141065T5 (es) |
GR (1) | GR990300042T1 (es) |
HK (1) | HK1022704A1 (es) |
NZ (1) | NZ334115A (es) |
RU (1) | RU2243234C2 (es) |
WO (1) | WO1998002457A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
US20020136739A1 (en) * | 1996-07-12 | 2002-09-26 | Cates George A. | Subunit respiratory syncytial virus preparation |
US6017694A (en) * | 1997-12-19 | 2000-01-25 | American Cyanamid Company | Methods of screening for modulators of respiratory syncytial virus matrix protein interaction |
ATE422364T1 (de) * | 1998-12-17 | 2009-02-15 | Sanofi Pasteur Ltd | Multivalente immunogenische zusammensetzung, die eine rsv untereinheit zusammensetzung und ein influenzavirus präparat enthält |
GB9909077D0 (en) * | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
WO2001006429A1 (en) * | 1999-07-15 | 2001-01-25 | Shea Robert S | Method of sequencing chronic disease testing, reporting and evaluation |
WO2001056602A2 (en) * | 2000-02-02 | 2001-08-09 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cd40 ligand adjuvant for respiratory syncytial virus |
FR2806912B1 (fr) * | 2000-04-04 | 2004-07-23 | Fond Mondiale Rech Et Preventi | UTILISATION DE PROTEINES gp120 ET gp160 MODIFIEES DANS LA BOUCLE V3 DU VIH-1 POUR LA PREPARATION DE COMPOSITIONS VACCINALES ET FORMULATIONS LES CONTENANT |
AU2001278337A1 (en) * | 2000-07-31 | 2002-02-13 | Aventis Pasteur Limited | Respiratory syncytial virus vaccine |
WO2002012289A2 (en) * | 2000-08-07 | 2002-02-14 | Aventis Pasteur Limited | Stabilization of immunogens derived from paramyxoviruses |
AU2002224416A1 (en) * | 2000-10-18 | 2002-04-29 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Compositions and methods for modulating RSV infection and immunity |
US7118888B2 (en) | 2001-09-28 | 2006-10-10 | University Of South Florida Board Of Trustees | Gene expression vaccine |
DE60219021T2 (de) * | 2001-12-20 | 2007-12-13 | Sanofi Pasteur Ltd., Toronto | Immunogene Zusammensetzungen, die ein Antigen und ein M-Protein des respiratorischen Synzytialviruses enthalten |
CA2484251C (en) | 2002-04-30 | 2015-06-23 | University Of South Florida | Materials and methods for inhibition of respiratory syncytial virus infection |
US7595303B1 (en) | 2002-09-05 | 2009-09-29 | University Of South Florida | Genetic adjuvants for immunotherapy |
WO2004083397A2 (en) * | 2003-03-18 | 2004-09-30 | Wyeth Holdings Corporation | Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
US7736648B2 (en) * | 2007-10-25 | 2010-06-15 | Trellis Bioscience, Inc. | Anti-RSV G protein antibodies |
SI2285408T1 (sl) | 2008-06-05 | 2019-02-28 | Ablynx N.V. | Aminokislinska zaporedja usmerjena proti proteinom ovojnicam virusa in polipeptidi, ki zaporedja vsebujejo za zdravljenje virusnih bolezni |
CN102307591B (zh) * | 2008-12-09 | 2016-08-03 | 诺瓦瓦克斯股份有限公司 | 修饰的rsv f蛋白及其使用方法 |
ES2643034T3 (es) * | 2009-06-05 | 2017-11-21 | Ablynx N.V. | Construcciones de Nanobody contra el virus respiratorio sincicial humano (VRSH) trivalentes para la prevención y/o el tratamiento de infecciones de las vías respiratorias |
EP4218799A1 (en) * | 2009-07-15 | 2023-08-02 | GlaxoSmithKline Biologicals S.A. | Rsv f protein compositions and methods for making same |
KR101789343B1 (ko) * | 2009-10-06 | 2017-10-23 | 메드임뮨 리미티드 | Rsv-특이적 결합 분자 |
AU2010334723C1 (en) * | 2009-12-23 | 2015-05-28 | Sanofi Pasteur | Method for culturing adherent cells |
CN102199198A (zh) * | 2011-03-28 | 2011-09-28 | 北京交通大学 | 人呼吸道合胞病毒f蛋白的纯化方法 |
EA201891945A3 (ru) | 2012-08-01 | 2019-05-31 | Бавариан Нордик А/С | Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv) |
US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
RU2761631C2 (ru) | 2013-03-13 | 2021-12-13 | Дзе Юнайтед Стэйтс Оф Америка, Эс Репрезентед Бай Дзе Секретэри, Департмент Оф Хелт Энд Хьюман Сервисиз | Белки rsv в предшествующей слиянию конформации и их применение |
JP6479305B2 (ja) * | 2013-07-12 | 2019-03-06 | 株式会社Umnファーマ | ウイルス様粒子の精製方法 |
US10377798B2 (en) * | 2013-12-02 | 2019-08-13 | The United States of America, as rerpresented by the Secretary, Department of Health and Human Services | Recombinant respiratory syncytial virus G protein fragments |
RU2746280C1 (ru) * | 2020-08-03 | 2021-04-12 | Федеральное государственное бюджетное научное учреждение "Федеральный исследовательский центр фундаментальной и трансляционной медицины" (ФИЦ ФТМ) | Штамм респираторно-синцитиального вируса RSV/Novosibirsk/66Hl/2018 для использования в диагностике респираторно-синцитиальной вирусной инфекции и исследования эффективности противовирусных препаратов in vitro |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987004185A1 (en) * | 1986-01-14 | 1987-07-16 | University Of North Carolina | Vaccines for human respiratory virus |
GB8914968D0 (en) * | 1989-06-29 | 1989-08-23 | Connaught Lab | Production of virus and purification of viral envelope proteins for vaccine use |
AU676340B2 (en) * | 1993-05-25 | 1997-03-06 | Wyeth Holdings Corporation | Adjuvants for vaccines against respiratory syncytial virus |
US20030072774A1 (en) | 1994-06-10 | 2003-04-17 | Diane M. Gajewczyk | Proteinaceous adjuvants |
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
-
1996
- 1996-07-12 US US08/679,060 patent/US6020182A/en not_active Expired - Lifetime
-
1997
- 1997-07-11 NZ NZ334115A patent/NZ334115A/en not_active IP Right Cessation
- 1997-07-11 JP JP10505475A patent/JP2000501418A/ja active Pending
- 1997-07-11 ES ES97930274T patent/ES2141065T5/es not_active Expired - Lifetime
- 1997-07-11 RU RU99102812/13A patent/RU2243234C2/ru not_active IP Right Cessation
- 1997-07-11 EP EP97930274A patent/EP0942928B2/en not_active Expired - Lifetime
- 1997-07-11 CN CNB97197862XA patent/CN1145639C/zh not_active Expired - Fee Related
- 1997-07-11 DE DE69731659T patent/DE69731659T3/de not_active Expired - Lifetime
- 1997-07-11 AT AT97930274T patent/ATE282633T1/de active
- 1997-07-11 WO PCT/CA1997/000497 patent/WO1998002457A1/en active IP Right Grant
- 1997-07-11 GR GR990300042T patent/GR990300042T1/el unknown
- 1997-07-11 US US09/214,605 patent/US6309649B1/en not_active Expired - Fee Related
- 1997-07-11 BR BR9712970-4A patent/BR9712970A/pt not_active Application Discontinuation
- 1997-07-11 CA CA002259594A patent/CA2259594C/en not_active Expired - Lifetime
- 1997-07-11 AU AU34311/97A patent/AU716378B2/en not_active Ceased
- 1997-07-11 DE DE0942928T patent/DE942928T1/de active Pending
- 1997-07-11 EP EP04018160A patent/EP1477494A1/en not_active Withdrawn
-
2000
- 2000-03-21 HK HK00101725A patent/HK1022704A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69731659D1 (de) | 2004-12-23 |
WO1998002457A1 (en) | 1998-01-22 |
CN1145639C (zh) | 2004-04-14 |
EP0942928B1 (en) | 2004-11-17 |
CA2259594A1 (en) | 1998-01-22 |
US6309649B1 (en) | 2001-10-30 |
RU2243234C2 (ru) | 2004-12-27 |
JP2000501418A (ja) | 2000-02-08 |
CA2259594C (en) | 2003-11-11 |
EP0942928A1 (en) | 1999-09-22 |
HK1022704A1 (en) | 2000-08-18 |
CN1230197A (zh) | 1999-09-29 |
AU3431197A (en) | 1998-02-09 |
DE942928T1 (de) | 2000-03-02 |
ATE282633T1 (de) | 2004-12-15 |
EP0942928B2 (en) | 2008-08-13 |
AU716378B2 (en) | 2000-02-24 |
DE69731659T2 (de) | 2006-03-02 |
NZ334115A (en) | 2000-06-23 |
EP1477494A1 (en) | 2004-11-17 |
ES2141065T3 (es) | 2005-05-01 |
BR9712970A (pt) | 2001-08-28 |
ES2141065T5 (es) | 2009-02-16 |
US6020182A (en) | 2000-02-01 |
DE69731659T3 (de) | 2009-06-18 |
GR990300042T1 (en) | 2000-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2141065T1 (es) | Preparacion de vacunas subunitarias contra el virus sincitial respiratorio. | |
ES2184869T3 (es) | Vacuna sub-unitaria contra la infeccion por flavivirus. | |
ATE72406T1 (de) | Vorrichtung zur applikation von implantaten. | |
AR059693A2 (es) | Una composicion farmaceutica de micofenolato y su uso | |
BR8905851A (pt) | Processo para a deteccao de uma infeccao por aids em seres humanos;composicao de proteina de involucro do virus de aids;e kit de teste utilizavel na administracao intradermica para deteccao de uma infeccao por aids | |
ES2074563T3 (es) | Procedimiento de preparacion de compuestos y metodo para el tratamiento de la septicemia y/o el choque septico. | |
BR9913406A (pt) | Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção | |
EA200100302A1 (ru) | Способы и композиции для протективной и терапевтической генетической иммунизации | |
ES2119185T3 (es) | Tratamiento de enfermedades micobacterianas por administracion de productos de la proteina bactericida/que aumenta la permeabilidad. | |
TR200103149T2 (tr) | Virüs ve mikoplazmanın korunması için yöntemler | |
SE9502474L (sv) | Farmaceutiska kompositioner för förhindrande och behandling av cancerösa sjukdomar samt process för beredning av dessa | |
AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
AR245451A1 (es) | Un metodo de obtener n-fosfonometilglicina purificada a partir de una solucion acuosa que contiene n-fosfonometilglicina y diversas impurezas. | |
ES2063796T3 (es) | Nuevos derivados de 2'-halometiliden, 2'-eteniliden- y 2'-etinil-adenosina. | |
DK482185A (da) | Peptider, deres fremstilling og anvendelse som laegemidler | |
WO1990013281A3 (en) | Method of suppressing hiv infection | |
ES2180750T3 (es) | Conjugado de un principio activo, un polieter y, en caso dado, una proteina nativa no considerada como exogena. | |
IT1233632B (it) | Impianto di disinfezione, in particolare per manipoli di riuniti dentali | |
WO2003022878A3 (en) | Subunit respiratory syncytial virus vaccine preparation | |
NO179855C (no) | Fremgangsmåte for fremstilling av et legemiddel | |
DE69709891D1 (de) | Chitosan enthaltende zusammensetzung | |
JPS57208943A (en) | Sterilization of cuttlefishes | |
FR2792639B1 (fr) | Nouveaux immunogenes anti-vih (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida | |
RU2001100614A (ru) | Средство для лечения заболеваний пародонта | |
ECSP972186A (es) | Composicion terapeutica proveniente de la caña de azucar y sus usos terapeuticos |